- Home
- BVN vs VRNA Comparison
BVN vs VRNA Comparison
Compare BVN & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVN
- VRNA
- Stock Information
- Founded
- BVN 1953
- VRNA 2005
- Country
- BVN Peru
- VRNA United Kingdom
- Employees
- BVN N/A
- VRNA N/A
- Industry
- BVN Metal Mining
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- BVN Basic Materials
- VRNA Health Care
- Exchange
- BVN Nasdaq
- VRNA Nasdaq
- Market Cap
- BVN 3.1B
- VRNA 3.4B
- IPO Year
- BVN 1996
- VRNA 2017
- Fundamental
- Price
- BVN $12.59
- VRNA $67.96
- Analyst Decision
- BVN Buy
- VRNA Strong Buy
- Analyst Count
- BVN 2
- VRNA 7
- Target Price
- BVN $16.50
- VRNA $57.14
- AVG Volume (30 Days)
- BVN 863.4K
- VRNA 1.3M
- Earning Date
- BVN 02-20-2025
- VRNA 02-27-2025
- Dividend Yield
- BVN 0.58%
- VRNA N/A
- EPS Growth
- BVN 1928.16
- VRNA N/A
- EPS
- BVN 1.59
- VRNA N/A
- Revenue
- BVN $1,154,605,000.00
- VRNA $5,624,000.00
- Revenue This Year
- BVN N/A
- VRNA N/A
- Revenue Next Year
- BVN N/A
- VRNA $571.44
- P/E Ratio
- BVN $8.24
- VRNA N/A
- Revenue Growth
- BVN 40.15
- VRNA 1127.95
- 52 Week Low
- BVN $11.50
- VRNA $11.39
- 52 Week High
- BVN $18.84
- VRNA $68.64
- Technical
- Relative Strength Index (RSI)
- BVN 42.72
- VRNA 76.88
- Support Level
- BVN $12.94
- VRNA $62.24
- Resistance Level
- BVN $13.50
- VRNA $65.50
- Average True Range (ATR)
- BVN 0.44
- VRNA 2.78
- MACD
- BVN -0.04
- VRNA 0.22
- Stochastic Oscillator
- BVN 12.60
- VRNA 94.86
About BVN Buenaventura Mining Company Inc.
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.